Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy
- PMID: 11920821
 - DOI: 10.1002/jmv.2195
 
Herpes simplex virus isolates with reduced adefovir susceptibility selected in vivo by foscarnet therapy
Abstract
Sequential herpes simplex virus (HSV) isolates from AIDS patients receiving foscarnet therapy were evaluated for susceptibility to adefovir. Foscarnet-resistant isolates with DNA polymerase mutations in regions II, VI, and between I and VII were also associated with an important decrease in susceptibility to adefovir (mean IC50 increase: 4.6-fold compared to pre-foscarnet or wild-type isolates) suggesting that adefovir-resistant HSV could be selected in vivo by foscarnet therapy.
Copyright 2002 Wiley-Liss, Inc.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
